{
    "Symbol": "AMGN",
    "AssetType": "Common Stock",
    "Name": "Amgen Inc",
    "Description": "Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.",
    "CIK": "318154",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "179990036000",
    "EBITDA": "11658000000",
    "PERatio": "47.86",
    "PEGRatio": "2.387",
    "BookValue": "9.36",
    "DividendPerShare": "8.64",
    "DividendYield": "0.0268",
    "EPS": "7.01",
    "RevenuePerShareTTM": "55.15",
    "ProfitMargin": "0.127",
    "OperatingMarginTTM": "0.133",
    "ReturnOnAssetsTTM": "0.0488",
    "ReturnOnEquityTTM": "0.726",
    "RevenueTTM": "29532000000",
    "GrossProfitTTM": "19917000000",
    "DilutedEPSTTM": "7.01",
    "QuarterlyEarningsGrowthYOY": "-0.524",
    "QuarterlyRevenueGrowthYOY": "0.22",
    "AnalystTargetPrice": "320.24",
    "AnalystRatingStrongBuy": "6",
    "AnalystRatingBuy": "10",
    "AnalystRatingHold": "12",
    "AnalystRatingSell": "2",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "47.86",
    "ForwardPE": "13.77",
    "PriceToSalesRatioTTM": "5.08",
    "PriceToBookRatio": "22.99",
    "EVToRevenue": "6.99",
    "EVToEBITDA": "13.31",
    "Beta": "0.58",
    "52WeekHigh": "346.85",
    "52WeekLow": "236.08",
    "50DayMovingAverage": "315.92",
    "200DayMovingAverage": "291.59",
    "SharesOutstanding": "536435000",
    "DividendDate": "2024-06-07",
    "ExDividendDate": "2024-05-16"
}